HypoglycemiaHyperglycemiaBlood GlucoseInsulinHypoglycemic AgentsDiabetes Mellitus, Type 1GlucoseHypertensionGlucagonHyperinsulinismDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedGlucose Clamp TechniqueEpinephrineDiabetes MellitusBlood PressureBlood Glucose Self-MonitoringPancreatic PolypeptideRisk FactorsInsulin Infusion SystemsInsulin, Long-ActingGlucose Tolerance TestC-PeptideTime FactorsStreptozocinInsulin ComaClinical AlarmsIslets of LangerhansFastingPrevalenceGluconeogenesisTreatment OutcomeVentromedial Hypothalamic NucleusDiabetes ComplicationsHydrocortisoneSulfonylurea CompoundsPostprandial PeriodAntihypertensive AgentsInsulin ResistanceNesidioblastosisInsulinomaCongenital HyperinsulinismSeverity of Illness IndexCross-Sectional StudiesNorepinephrineObesityRetrospective StudiesBody WeightReference ValuesInsulin-Secreting CellsRats, Sprague-DawleyPancreas, ArtificialGlipizideHomeostasisGlucokinaseProspective StudiesQuestionnairesAwarenessFollow-Up StudiesPregnancy in DiabeticsBlood Pressure DeterminationLiverInfant, NewbornFatty Acids, NonesterifiedDiabetic KetoacidosisAge FactorsDiabetic AngiopathiesGlucagon-Like Peptide 1Diazoxide3-Hydroxybutyric AcidCritical IllnessInsulin AntibodiesGlycosuriaDisease Models, AnimalCardiovascular DiseasesCohort StudiesRats, WistarDepressionBody Mass IndexMonitoring, AmbulatoryBrainInfusions, IntravenousSymptom AssessmentPancreasInsulin LisproInsulin AspartMetabolic Syndrome XInsulin, IsophanePregnancyPancreatectomyPhlorhizinMetforminInfusions, SubcutaneousSex FactorsDipeptidyl-Peptidase IV InhibitorsUnited StatesHuman Growth HormoneDiabetic NeuropathiesLactic Acid